Cellular Biomedicine Group, Inc. (CBMG): Price and Financial Metrics


Cellular Biomedicine Group, Inc. (CBMG)

Today's Latest Price: $12.71 USD

0.48 (-3.64%)

Updated Jun 5 4:00pm

Add CBMG to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 115 in China

See all "A" rated Strong Buy stocks

CBMG Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for CBMG is 0.01 -- better than merely 8.63% of US stocks.
  • CBMG's price/sales ratio is 879.98; that's higher than the P/S ratio of 99.47% of US stocks.
  • With a year-over-year growth in debt of 128.32%, Cellular Biomedicine Group Inc's debt growth rate surpasses 89.21% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Cellular Biomedicine Group Inc, a group of peers worth examining would be ADAP, MRSN, GERN, INO, and CRNX.
  • CBMG's SEC filings can be seen here. And to visit Cellular Biomedicine Group Inc's official web site, go to www.cellbiomedgroup.com.
CBMG Daily Price Range
CBMG 52-Week Price Range

CBMG Stock Price Chart More Charts


CBMG Price/Volume Stats

Current price $12.71 52-week high $18.99
Prev. close $13.19 52-week low $10.98
Day low $12.60 Volume 79,014
Day high $13.46 Avg. volume 68,155
50-day MA $14.55 Dividend yield N/A
200-day MA $15.53 Market Cap 246.46M

Cellular Biomedicine Group, Inc. (CBMG) Company Bio


Cellular Biomedicine Group develops treatments for cancerous and degenerative diseases in China. The company was incorporated in 2001 and is based in Palo Alto, California.


CBMG Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CBMG Latest Social Stream


Loading social stream, please wait...

View Full CBMG Social Stream

Latest CBMG News From Around the Web

Below are the latest news stories about Cellular Biomedicine Group Inc that investors may wish to consider to help them evaluate CBMG as an investment opportunity.

Edited Transcript of CBMG earnings conference call or presentation 6-May-20 9:00pm GMT

Q1 2020 Cellular Biomedicine Group Inc Earnings Call

Yahoo | June 2, 2020

Hedge Funds Are Warming Up To Cellular Biomedicine Group, Inc. (CBMG)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2020. […]

Yahoo | May 27, 2020

Cellular Biomedicine Group (CBMG) Announces 2020 Annual Meeting of Stockholders

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, has announced that the 2020 Annual Meeting of Stockholders (the "Annual Meeting") will be held at 9:00 a.m. Eastern Standard Time on Friday, June 26, 2020, at Aloft Long Island City – Manhattan View, 27-45 Jackson Avenue, Long Island City, New York 11101. Stockholders of record as of April 27, 2020 are authorized and asked to vote in the manner directed in the proxy materials.

Yahoo | May 26, 2020

Cellular Biomedicine Group Inc (CBMG) Q1 2020 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by, and welcome to the Cellular Biomedicine Group, Inc. First Quarter 2020 Results Conference Call. Speaking today is Chief Executive Officer and Chief Financial Officer of Cellular Biomedicine Group, Tony Liu. For more information, please refer to the risk factors discussed in CBMG's most recently filed periodic reports on Form 10-K and Form 10-Q. Cellular Biomedicine Group assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

Yahoo | May 7, 2020

Cellular Biomedicine Group Reports Q1 2020 Financial Results and Business Highlights

NEW YORK and SHANGHAI, May 6, 2020 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today reported business…

PR Newswire | May 6, 2020

Read More 'CBMG' Stories Here

CBMG Price Returns

1-mo -9.21%
3-mo -21.35%
6-mo -25.76%
1-year -14.18%
3-year 80.28%
5-year -66.55%
YTD -21.74%
2019 -8.04%
2018 56.98%
2017 -14.12%
2016 -39.04%
2015 66.46%

Continue Researching CBMG

Want to see what other sources are saying about Cellular Biomedicine Group Inc's financials and stock price? Try the links below:

Cellular Biomedicine Group Inc (CBMG) Stock Price | Nasdaq
Cellular Biomedicine Group Inc (CBMG) Stock Quote, History and News - Yahoo Finance
Cellular Biomedicine Group Inc (CBMG) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9741 seconds.